Matthew Majewski


Reducing Prescription Drug Costs for Seniors: The ABCs of ASP for Part D

Outlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.

Pricing for Rare Disease and Curative Therapies: What’s Fair?

There has been a considerable amount of attention given to the rising costs of pharmaceutical and biotechnology therapies in the US. In early 2020, Charles River Associates conducted this research to determine what "fair" prices would be for these therapies.